3D Printing Market Analysis By Application, Raw Material And Segment Forecast Up To 2020

Global 3D Printing Market was estimated to be USD 2,183 million in 2012, and is expected to reach USD 8,675.7 million by 2020, as per a new study by Grand View Research, Inc. The ability to facilitate low-volume manufacturing in a cost-effective manner is expected to fuel the market over the next few years. Further, the report analyses that the growing need for flexible and customized products is expected to positively impact demand for 3D printing.

Automotive and healthcare industries in particular, are estimated to be key growth areas for revenue generation. Automotive is expected to be the largest and fastest growing application, with an estimated CAGR of 19.6% from 2013 to 2020. The market for medical applications was valued at USD 397.2 million in 2012, with dental applications expected to contribute largely to this segment. Concerns over protection of intellectual property from products manufactured using 3D printing are expected to restrain the industry from reaching its target potential. Backward integration in the value chain in terms of acquisitions of software 3D designing participants has been analyzed to be an opportunity for gaining competitive advantage.

Full Research Report On Global 3D Printing (3DP) Market Analysis: http://www.grandviewresearch.com/industry-analysis/3d-printing-industry-analysis

Further Key findings from the study suggest:

• North America led the market, with approximately 42% of the overall market share in 2012
• Europe is expected to grow at the highest CAGR of 20.4% from 2013 to 2020, which can primarily be attributed to increase in funding from regulatory bodies. Furthermore, increasing investment in research and development are expected to be favorable factors for market expansion in this region
• In terms of raw material used for manufacturing, polymers are expected to dominate the market, and accounted for more than 35% of the overall revenue in 2012
• The industry is moderately consolidated, with mergers and acquisitions emerging as the key growth strategy. Major industry participants include Stratasys Inc., 3D Systems Corporation, Envisiontec GmbH, and Materialise NV among others.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research’s report estimates the market in terms of revenue (USD Million) and segments it as follows:

3D Printing Application Outlook:

• Automotive
• Aerospace
• Consumer Products
• Medical
• Others

3D Printing Raw Material Outlook:

• Polymers
• Metals
• Ceramic
• Others

3D Printing Regional Outlook:

• North America
• Europe
• Asia Pacific
• Rest of the World (RoW)

View Blog on Global 3D Printing (3DP) Market by Grand View Research: http://www.grandviewresearch.com/blog/3d-printing-industry   

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Live Cell Imaging Market Is Projected To Reach USD 9.0 billion by 2025

Global Live Cell Imaging Market is expected to reach USD 9.0 billion by 2025, according to a new report by Grand View Research, Inc. Rising popularity of kinetic research over fixed cellular analysis is the key driver. Addition of dyes and reagents alter the cell behavior, mostly in a negative manner, which does not showcase the natural course of action of the cellular functions. 

Understanding the cellular behavior in its natural state is crucial in drug discovery and targeted drug therapy. This, in turn, increases the need for live cell imaging, thus boosting the market.

In a survey by Drug Discovery World Spring, almost 21% researchers prefer & use live cell imaging and 31% plan to use it in the future. Moreover, 38% of the respondents were interested in using live cell kinetic HCS imaging in the future. The most important feature for researchers is the ability to automate the incubation and image capturing of any live cell analyzer. Secondly, they also give importance to viable cell-tracking ability of the equipment. Further development in the technology of equipment is expected to fulfill these criteria and boost the utility of the same over the forecast period.

Development in delivering probes in living cells, targeting organelles, and proteins using some of the techniques has increased use and adoption of live cell imaging in research and other applications. With improved fluorescent probes, the techniques such as Fluorescence Resonance Energy Transfer (FRET) share a majority of the share.

Full Research Report on Global Live Cell Imaging Market Analysis: http://www.grandviewresearch.com/industry-analysis/live-cell-imaging-market

Further Key Findings From The Report Suggest:

• Equipment dominated the product segment in 2016. The current system, although of great potential are still expected to perform better over the next few years. The general trend is to make the instruments compact and integrated for end-to-end processing.
• Cell biology dominated the application with more than 30% of the shares and was closely followed by developmental biology. Stem cell and drug discovery are the upcoming fields to apply live cell imaging in the research.
• North America dominated due to its high investment rate and technologically sound infrastructure. The research firms present in this region are technologically aware, hence, readily invest in high cost equipment.
• Asia Pacific is expected to show fastest growth over the forecast period due to increasing application of these imaging techniques in drug discovery and personalized medicine.
• Key players includes Carl Zeiss Meditec AG; Leica Microsystems; Nikon Corporation; Becton, Dickinson and Company; GE Healthcare; Olympus Corporation; Thermo Fisher Scientific Inc.; Sigma-Aldrich Corporation; PerkinElmer, Inc.; and Molecular Devices, LLC

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the Global Live Cell Imaging Market on the basis of product, application, technology, and region:

Live Cell Imaging Product Outlook (Revenue, USD Million, 2014 - 2025)

• Equipment
• Consumable
• Software

Live Cell Imaging Application Outlook (Revenue, USD Million, 2014 - 2025)

• Cell Biology
• Developmental Biology
• Stem Cell & Drug Discovery
• Others

Live Cell Imaging Technology Outlook (Revenue, USD Million, 2014 - 2025)

• Time lapse Microscopy
• Fluorescence recovery after photobleaching (FRAP)
• Fluorescence resonance energy transfer (FRET)
• High content screening (HCS)
• Others

Live Cell Imaging Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• Japan
• Latin America
• Brazil
• Mexico
• MEA
• South Africa 

View press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-live-cell-imaging-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Mixed Tocopherols Market Is Anticipated To Observe Sluggish Growth At A CAGR Of 2.4% From 2017 To 2025

Global Mixed Tocopherols Market is expected to reach USD 11.9 billion by 2025, according to a new report by Grand View Research, Inc. Rising vitamin E demand in food and dietary supplements owing to rising health concerns is expected to plays a significant role in promoting the industry growth over the next few years. The global market is anticipated to observe sluggish growth at a CAGR of 2.4% from 2017 to 2025.

Alpha rich tocopherols was the leading product segment and is anticipated to grow at a CAGR of 2.3%, by revenue, over the forecast period. The segment is expected to gain share over the forecast period owing to high demand in dietary supplements. Health benefits associated with vitamin E to treat deficiency and diseases such as lung, oral, colorectal and pancreatic cancer; polyps, and gastric are also anticipated to drive the mixed tocopherols market in pharmaceuticals over the forecast period.

Full Research Report on Global Mixed Tocopherols Market Analysis:http://www.grandviewresearch.com/industry-analysis/mixed-tocopherols-industry

Further key findings from the report suggest:

• The global mixed tocopherols demand was 117.8 kilo tons in 2016 and is estimated to grow at a CAGR of 3.6% from 2017 to 2025
• Mixed tocopherols demand in dietary supplements was 50.9 kilo tons in 2016 and is anticipated to witness moderate growth over the next eight years
• Product demand in animal feed nutrition is anticipated to emerge as the fastest growing application segment, and generate revenues worth over USD 2 billion by 2025
• Mixed tocopherols demand in North America is projected to reach USD 3.6 billion by 2025 and is estimated to grow as a significant rate from 2017 to 2025
• The U.S. gamma rich tocopherols demand is anticipated to emerge as the fastest growing market in North America and is expected to reach total volume of over 5.6 kilo tons by 2025
• The industry in Europe is projected to witness moderate growth of 2.9% from 2017 to 2025 owing to the increased use of mixed tocopherols as antioxidants and feed additives
• Asia Pacific was the dominant consumer in 2016. High rate of dietary supplements, animal feed, and pharmaceuticals manufacturing in key economies including China, Japan, and India is the major factor for industry penetration.
• Key industry participants such as BASF, DSM, ADM, and Cargill dominated the global mixed tocopherol market over the next few years. The major players operating in the mixed tocopherol market comprise, BTSA, Vitae Naturals, Zhejiang Medicine Co., Ltd. (ZMC), COFCO Tech Bioengineering Co., Ltd., Eisai Food & Chemical Co., Ltd., and Vance Group Ltd.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/food-additives-nutricosmetics-flavors-and-fragrances

Grand View Research has segmented the Global Mixed Tocopherols Market on the basis of product, application, and region:

Mixed Tocopherols Product Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• Alpha Rich
• Gamma Rich
• Gamma-Delta Rich
• Others

Mixed Tocopherols Application Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• Dietary Supplements
• Animal Feed Nutrition
• Cosmetics
• Pharmaceuticals
• Food & Beverage Fortification

Mixed Tocopherols Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• Asia Pacific
• China
• India
• Central & South America
• Middle East & Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-mixed-tocopherols-market               

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Narcolepsy Therapeutics Market Size Projected To Reach $3.85 Billion By 2025

Global Narcolepsy Therapeutics Market is expected to reach USD 3.85 billion by 2025, according to a new report by Grand View Research, Inc. The increasing awareness about this sleep disorder among public and healthcare providers is a key factor contributing to the market growth.

The Narcolepsy Network has estimated that out of every 2,000 people 1 is afflicted by this condition. Moreover, Narcolepsy UK states that around 25% patients are identified and remaining 75% are untreated as they remain undiagnosed or are misdiagnosed, which is alarming. Some organizations and networks are constantly working to spread awareness about this condition among the patients and physicians.

Full Research Report on Global Narcolepsy Therapeutics Market Analysis:  
http://www.grandviewresearch.com/industry-analysis/narcolepsy-therapeutics-market

Further key findings from the report suggest:

• The narcolepsy therapeutics market is expected to grow substantially owing to the worldwide increasing incidence of this disorder.
• Narcolepsy with cataplexy was identified as the largest type segment in 2016. It is expected to retain its position throughout the forecast period owing to the rising cases of cataplexy in patients suffering from narcolepsy.
• Narcolepsy without cataplexy is likely to witness the fastest growth over the forecast period due to increasing awareness about Excessive Daytime Sleepiness (EDS) through various mediums, such as awareness campaigns
• Sodium oxybate dominated the product segment in terms of revenue share in the year 2016, and it is also expected to be the fastest growing segment over the forecast period. Drugs belonging to this class have higher costs and favorable coverage policies.
• Xyrem is the only FDA-approved drug in this category and is extensively prescribed for the treatment of cataplexy and EDS. American Academy of Sleep Medicine (ASSM) recommends it as a standard treatment of this disorder.
• Europe dominated the regional market in terms of revenue share in 2016 because of increase in capital investments and existence of established healthcare infrastructure along with a large target population
• The H1N1 influenza postvaccination pandemic of the year 2009 has resulted in growth of number of narcolepsy patients
• Asia Pacific is likely to exhibit fastest growth during the forecast period due to the rising healthcare expenditure in this region, rising awareness among people, highest prevalence in Japan, and presence of emerging economies such as China & India
• Some of the major market players are Jazz Pharmaceuticals PLC;Teva Pharmaceutical Industries Ltd.;Graymark Healthcare, Inc.;Addrenex Pharmaceuticals, Inc.; and BIOPROJET.
• Mergers and acquisitions are strategic initiatives undertaken by these market players in an attempt to remain competitive. In addition, companies are expanding their geographical presence to untapped markets.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Global Narcolepsy Therapeutics Market on the basis of type, product, and region:

Narcolepsy Therapeutics Type Outlook (Revenue, USD Million, 2014 - 2025)

• Narcolepsy with Cataplexy
• Narcolepsy Without Cataplexy
• Secondary Narcolepsy

Narcolepsy Therapeutics Product Outlook (Revenue, USD Million, 2014 - 2025)

• Central Nervous System Stimulants
• Sodium Oxybate
• Selective Serotonin Reuptake Inhibitor
• Tricyclic Antidepressants
• Others

Narcolepsy Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Middle East & Africa
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-narcolepsy-therapeutics-market               

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

U.S. Food Container Market Is Projected To Reach $51.92 Billion By 2025

U.S. Food Container Market is projected to reach USD 51.92 billion by 2025, according to a new report conducted by Grand View Research, Inc. Rising expenditure towards improving nutritional supplementation by gym professionals and athlete is expected to promote the usage of milk and whey ingredients in the formulation sports nutrition goods. In addition, product innovation in baby care products including infant milk formula by Unilever and Nestle in the U.S. is expected to upscale the requirements of containers as packaging medium for milk powder and whey ingredients over the forecast period.

Meat processed goods are projected to grow at a CAGR of 4.7% from 2016 to 2025. High prevalence of production sites of meat processing companies including Tyson Foods, JBF, Cargill and National Beef is projected to keep extensive market reach for packaging products over the next nine years.

Full Research Report on U.S. Food Container Market Analysis:  
http://www.grandviewresearch.com/industry-analysis/us-food-container-market

Further key findings from the report suggest:

• U.S. food container industry is expected to reach USD 51.92 billion by the end of 2025, expanding at a CAGR of 3.4% from 2016 to 2025. Product innovation by convenience food manufacturers is expected to remain a key driving force in the near future.
• Flexible packaging is expected to foresee revenue growth at a CAGR of 4.0% from 2016 to 2025. Shifting inclination from conventional glass and metal to lightweight polymers including polyethylene (PE) and polyvinyl diene chloride (PVC) as a raw material for packaging of food items is expected to be a favorable factor.
• Paperboard market was valued at USD 7.69 billion in 2015. The product is expected to foresee significant gains in packaging dry goods including chips, sausages, burgers and sandwiches.
• Bakery products are projected to account for 17.8% of global market share by the end of 2025. Increment in sales of Pizza Crusts, Cakes & Pastries as a result of product innovation by bakery processing companies including Group Bimbo is expected to expand the scope of packaging.
• Key vendors include Berry Plastics, Bemis, Silgan Holdings, Amcor, Ball Corporation, Ardagh Group, Sealed Air Corporation, and Graham Packaging. In October 2013, Silgan Holdings Inc. completed the acquisition of leading plastic closure manufacturer, Portola Packaging, Inc., for approximately USD 265 million. This acquisition is expected to result in increasing the availability of plastic closures for the captive production of containers used in the food & beverage industry.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/food-safety-and-processing

Grand View Research has segmented the U.S. Food Container Market on the basis of product and application:

U.S. Food Container Product Outlook (Revenue, USD Million; 2014 - 2025)

• Flexible Packaging
• Paperboard
• Rigid Packaging
• Metal
• Glass

U.S. Food Container Application Outlook (Revenue, USD Million; 2014 - 2025)

• Grain Mill Products
• Dairy Goods
• Fruits & Vegetables
• Bakery Products
• Meat Processed Products
• Others

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/us-food-container-market-analysis              

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Aerosol Valves Market Size Is Projected To Reach $1.87 Billion By 2025

Global Aerosol Valves Market is expected to reach USD 1.87 billion by 2025, growing at a CAGR of 5.5%, according to a new report by Grand View Research, Inc. Rising demand for aerosol based household cleaners is expected to emerge as a major factor driving growth. In addition, growth in the demand for easy to use products due to widening consumer acceptance is likely to drive growth.

The raw materials required for the product manufacture such as springs, dip tubes, and coatings are procured from low cost suppliers. The industry witnesses the production of highly customized products with the specifications varying with the can design. In addition, the wide availability of raw materials results in a diminished supplier power for the manufacturers.

The industry is characterized by the presence of stringent regulations by agencies, pertaining to the raw material grades and coatings used in the valve systems. However, the industry is expected to witness limited regulations, primarily in Asia Pacific, thereby realizing high growth.

Introduction of innovative products by key FMCG manufacturers such as P&G and Unilever in high potential markets including China and India in light of expansion of the domestic retail markets is expected to promote the usage of such products. This trend is expected to expand the market size over the forecast period. 

Full Research Report on Global Aerosol Valves Market Analysis: http://www.grandviewresearch.com/industry-analysis/aerosol-valve-market

Further key findings from the report suggest:

• The demand for aerosol valves for personal care products accounted for 35.8% of the consumption volume in 2016, driven by rising sales of products such as deodorants, hairsprays and shaving creams
• The demand for continuous valves in household segment is expected to register a CAGR of 4.9% by revenue from 2017 to 2025 due to heightened product consumption envisaged by limited human interaction with aerosol cleaners
• The demand other valves including bag-on-valves in the food segment is likely to register a CAGR of 5.8% from 2017 to 2025 due to superior product performance for dispensing food products
• The market in North America accounted for a consumption of 4,682.8 million valves due to high aerosol production in the U.S. The industry is expected to grow in the wake of high adoption levels coupled with increasing penetration levels
• China is estimated to account for an industry revenue of USD 102.4 million in 2016, on account of low cost production coupled with superior economies of scales achieved by the manufacturers in the economy
• Key players including Mitani Valve and Coster Group lay high emphasis on capacity increases in order to gain market share and increase the company revenues

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/advanced-materials

Grand View Research has segmented the Global Aerosol Valves Market on the basis of application, and region:

Aerosol Valves Application Outlook (Volume, Million Units; Revenue, USD Million, 2014 - 2025)

• Personal Care
• Continuous Valves
• Metered Valves
• Other Valves
• Household
• Continuous Valves
• Other Valves
• Automotive & Industrial
• Continuous Valves
• Other Valves
• Food
• Continuous Valves
• Other Valves
• Paints
• Continuous Valves
• Other Valves
• Medical
• Continuous Valves
• Metered Valves
• Other Valves
• Others
• Continuous Valves
• Metered Valves
• Other Valves

Aerosol Valves Regional Outlook (Volume, Million Units; Revenue, USD Million, 2014 - 2025)

·         North America

§  U.S.

§  Canada

§  Mexico

·         Europe

§ Germany

§  UK

§  Italy

§  France

·         Asia Pacific

§  China

§  India

§  Japan

·         Central & South America

§  Brazil

·         Middle East & Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-aerosol-valve-market              

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Transplant Diagnostic Market Forecasting Include Market Drivers And Restraints, Along With Their Current And Expected Impacts 2024

Global Transplant Diagnostic Market is expected to reach USD 895.2 million by 2024, according to a new report by Grand View Research Inc. The rising demand for organ transplantation is primarily fuelling the demand for transplant diagnostics.

Constant healthcare research and development efforts are resulting in the introduction of technically advanced treatments, such as stem cell therapy and organ transplants. As a result, the adoption of these highly-advanced organ transplantation techniques is creating the demand for transplant diagnostics as they reduce the risk of infections and minimize the chances of an immune response through pre-operative assessments including histocompatibility tests, such as Human Leukocyte Antigen (HLA) typing, which determines donor-receiver organ or tissue compatibility prior to organ transplants.

In addition, pertinent organizations are supporting research and development initiatives in the field of organ transplant through grants and funding. As a result, innovative and advanced diagnostic tools are frequently entering into the market. On the other hand, high cost of the diagnostic tests is one of the major factors hindering the growth of the market.

Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa (MEA). North America and Europe together accounted for the largest market share in 2015. Developed economies and well-established healthcare infrastructure coupled with the presence of a highly developed research infrastructure are accelerating the adoption of organ and tissue transplant therapies in Europe and North America. As a consequence, the demand for transplant diagnostics is high in North America and Europe. 

Wide adoption of HLA typing owing to its ability to determine organ compatibility between the donor and the receiver preceding organ transplants and to predict potential perioperative immunological complications is driving the growth of the molecular assay market in North America and Europe. 

Asia Pacific is expected to show the fastest growth rate during the forecast period owing to the booming medical tourism in countries, such as India. Availability of advanced healthcare infrastructure and skilled professionals at a lower cost are anticipated to attract patients worldwide to this region for transplant procedures. 

In addition, the presence of highly advanced healthcare infrastructure and the ongoing government initiatives to improve healthcare facilities in the country are collectively anticipated to boost the market growth in Japan during the forecast period. As a result, the Asia Pacific market is anticipated to reach USD 216.6 million in 2024. 

Full Research Report on Global Transplant Diagnostic Market Analysis: http://www.grandviewresearch.com/industry-analysis/transplant-diagnostic-market

Further key findings from the study suggest:

• The PCR-based molecular assay captured the largest share of the overall market in 2015. The large market share was mainly attributed to the extensive adoption of the PCR technique in HLA typing.
• The sequencing-based typing segment is anticipated to witness significant growth rate from 2016 to 2024. The escalation in the adoption of next generation sequencing (NGS) is the major factor expected to drive the growth of this segment during the forecast period.
• The integration of sequencing with serological typing enhances diagnostic outcomes and, hence is expected to augment the growth of the sequencing segment during the forecast period
• The reagents and consumables segment accounted for the largest market share in 2015. This large share is mainly attributed to the repeat purchase of these products.
• North America captured the largest market share of around 38% in 2015 and is expected to maintain its dominance throughout the forecast period. Well-established research infrastructure, the increasing healthcare expenditure, high adoption rate of the advanced diagnostic techniques, and the growing R&D activities are some of the factors supporting the growth of the market in the region.
• Asia Pacific is expected to witness significant growth during the forecast period owing to the expanding research opportunities, the increasing health care expenditure, and the rising awareness of organ donation in the region.
• The booming medical tourism industry offers further growth opportunities for the market in Asia Pacific
• Some major players in this market include Thermo Fisher Scientific, Inc., Illumina, Inc., F.Hoffmann La-Roche AG. Abbott Laboratories, Inc., Qiagen N.V., Immucor Transplant Diagnostics, Inc., Bio-Rad Laboratories, Inc., Affymetrix, Inc., and Omixon Ltd. 

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/healthcare

Grand View Research has segmented the Global Transplant Diagnostic Market on the basis of technology, product, and geography. 

Transplant Diagnostic Market by Technology, 2013 - 2024 (USD Million)      

• Molecular Assays

·         PCR-Based Molecular Assays

·         Sequencing-Based Molecular Assays

• Non-Molecular Assays

·         Serological Assays

·         Mixed Lymphocyte Culture (MLC) Assays

Transplant Diagnostic Market by Product, 2013 - 2024 (USD Million)       

• Reagents and Consumables 
• Instruments    
• Software and Services 

Transplant Diagnostics Market, by Region, 2013- 2024 (USD Million)

• North America

·         U.S. Transplant Diagnostics Market by Product Type

·         Canada Transplant Diagnostics Market by Product Type

·         U.S.Transplant Diagnostics Market by Technology Type

·         Canada Transplant Diagnostics Market by Technology

• Europe

·         Germany Transplant Diagnostics Market by Product Type

·         France Transplant Diagnostics Market by Product Type

·         Germany Transplant Diagnostics Market by Technology

·         France Transplant Diagnostics Market by Technology

• Asia Pacific

·         China Transplant Diagnostics Market by Product Type

·         India Transplant Diagnostics Market by Product Type

·         China Transplant Diagnostics Market by Technology

·         India Transplant Diagnostics Market by Technology

• Latin America

·         Brazil Transplant Diagnostics Market by Product Type

·         Mexico Transplant Diagnostics Market by Product Type

·         Brazil Transplant Diagnostics Market by Technology

·         Mexico Transplant Diagnostics Marketby Technology

• MEA

·         South Africa Transplant Diagnostics Market by Product Type

·         South Africa Transplant Diagnostics Market by Technology

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-transplant-diagnostic-market    

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com